On Wednesday, Shares of JetBlue Airways Corporation (NASDAQ:JBLU), gained 6.42% to $23.53.
JetBlue Airways Corporation, declared an exclusive live performance by one of the most iconic singing groups of all time, Boyz II Men. The airline known for its award-winning customer experience will provide a very special concert by the GRAMMY Award-winning group on Thursday, September 24, 2015 at 5 p.m. at John F. Kennedy International Airport’s Terminal 5. This concert will only be available to lucky travelers and concert ticket winners.
JetBlue has also collaborated with The Mirage Hotel & Casino in Las Vegas to provide a once-in-a-lifetime opportunity for Boyz II Men’s most devoted fans. Fans from New York and Boston can enter to receive travel accommodations to New York to see the best-selling R&B group of all time perform at T5, followed by a meet and greet with the trio. Right away after the show, these winners will then fly with Boyz II Men to Las Vegas and have the opportunity to see the group perform at the Terry Fator Theatre at The Mirage.
“JetBlue’s Live From T5 concerts offer our customers an experience so unique and entertaining, hopefully they won’t forget they actually have a flight to catch,” said Don Uselmann, general manager, airport operations, JetBlue. “Like JetBlue, the group has a fresh approach. JetBlue defined what the air travel experience should be and Boyz II Men created a timeless sound. We’re excited to offer this once-in-a-lifetime experience to our mutual fans.”
JetBlue Airways Corporation, a passenger carrier company, provides air transportation services. As of December 31, 2014, the company operated a fleet of 13 Airbus A321 aircrafts, 130 Airbus A320 aircrafts, and 60 EMBRAER 190 aircrafts.
Shares of WPCS International Incorporated (NASDAQ:WPCS), inclined 26.61% to $1.57, during its last trading session.
WPCS International Incorporated declared that it was awarded $3.0 million in new contracts during the months of July and August 2015.
According to Sebastian Giordano, Interim CEO of WPCS, “Suisun City remains a profitable operation, performing as predictable during the first four months of the fiscal year ended April 30, 2016. Since our business has historically been strongest in the third and fourth quarters, we look forward to building upon this positive news as the year unfolds.”
These new projects comprise a $1.4 million contract to provide low voltage structured cabling and telecommunications closet build outs for Sutter Coast Hospital, an 80,000 square foot general medical and surgical hospital with 49 beds, located in Crescent City, California. In addition, the Company was also awarded $1.6 million in new work from existing customers.
WPCS International Incorporated provides low voltage communication infrastructure services in the public services, healthcare, energy, and corporate enterprise markets worldwide.
Finally, AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), ended its last trade with 6.58% gain, and closed at $64.99.
AMAG Pharmaceuticals declared that company administration will discuss AMAG’s business and financial outlook, strategy and growth prospects at the following investor conferences taking place in September 2015.
- FBR Second Annual Healthcare Conference
One-on-one meetings only: Wednesday, September 9, 2015
Location: Boston, MA
- Baird 2015 Healthcare Conference
Presentation: Thursday, September 10, 2015 at 7:55 a.m. ET
One-on-one meetings: Thursday, September 10, 2015
Location: New York, NY
- Jefferies Mid-Atlantic Corporate Access Day
One-on-one meetings only: Friday, September 11, 2015
Location: Baltimore, MD
- Morgan Stanley Global Healthcare Conference
Fireside chat: Wednesday, September 16, 2015 at 5:25 p.m.
One-on-one meetings: Wednesday, September 16, 2015 and Thursday, September 17, 2015
Location: New York, NY
AMAG Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that focuses on maternal health, anemia, and cancer supportive care. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women with a singleton pregnancy; Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the administration of oral mucocitis/stomatiits and various types of oral wounds.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
